Viking Therapeutics Inc. (VKTX)
NASDAQ: VKTX
· Real-Time Price · USD
40.04
-0.20 (-0.50%)
At close: Aug 15, 2025, 3:59 PM
40.74
1.75%
After-hours: Aug 15, 2025, 07:57 PM EDT
Viking Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -11.33 | -14.83 | -31.63 | -70.39 | -68.62 | -75.16 | -18.93 | -12.26 | -20.87 | -17.61 | -9.56 | -3.39 | -3.19 | -3.64 | -7.16 | -9.25 | -7.58 | -8.45 |
PEG Ratio | -0.27 | -0.53 | -0.7 | -7.04 | 2.97 | -18.79 | -2.18 | -0.58 | 1.00 | 4.40 | -0.38 | 0.26 | -0.34 | -0.12 | 1.22 | 0.62 | -1.44 | -0.32 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | 4.27K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 3.74 | 3.20 | 5.09 | 7.70 | 6.63 | 8.81 | 5.35 | 3.00 | 4.16 | 9.73 | 4.95 | 1.38 | 1.35 | 1.27 | 1.75 | 2.30 | 2.07 | 2.00 |
P/FCF Ratio | -63.14 | -51.72 | -143.69 | -319.72 | -214.18 | -1.34K | -105.62 | -56.23 | -140.35 | -52.94 | -65.89 | -15.42 | -16.56 | -22.05 | -28.65 | -44.84 | -34.73 | -43.52 |
P/OCF Ratio | -63.14 | -51.72 | -143.69 | -319.72 | -214.18 | -1.34K | -105.62 | -56.23 | -140.35 | -52.94 | -65.89 | -15.42 | -16.56 | -22.05 | -28.65 | -44.84 | -34.73 | -43.52 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | -40.46 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Quick Ratio | 25.86 | 44.25 | 33.09 | 36.47 | 37.69 | 29.48 | 19.19 | 28.44 | 29.63 | 9.55 | 7.61 | 11.74 | 12.10 | 17.15 | 23.98 | 19.76 | 18.46 | 19.35 |
Current Ratio | 25.86 | 44.25 | 33.09 | 36.47 | 37.69 | 29.48 | 19.19 | 28.44 | 29.63 | 9.55 | 7.61 | 11.74 | 12.10 | 17.15 | 23.98 | 19.76 | 18.46 | 19.35 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | -1.93K | -1.52K | -1.89K | -1.22K | -1.13K | -13.63K | -741.88 | -733.46 | -2.54K | -599.85 | -1.47K | -1.35K | -1.04K | n/a | -740.05 | -677.52 |
Return on Equity | -0.08 | -0.05 | -0.04 | -0.03 | -0.02 | -0.03 | -0.07 | -0.06 | -0.05 | -0.14 | -0.13 | -0.1 | -0.11 | -0.09 | -0.06 | -0.06 | -0.07 | -0.06 |
Return on Assets | -0.08 | -0.05 | -0.04 | -0.03 | -0.02 | -0.03 | -0.07 | -0.06 | -0.05 | -0.12 | -0.11 | -0.09 | -0.1 | -0.08 | -0.06 | -0.06 | -0.06 | -0.06 |
Return on Invested Capital | -0.09 | -0.07 | -0.05 | -0.04 | -0.04 | -0.04 | -0.08 | -0.07 | -0.06 | -0.14 | -0.13 | -0.1 | -0.11 | -0.09 | -0.06 | -0.06 | -0.07 | -0.06 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | 0.83 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | -56.43 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | -56.43 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | -67.17 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | -67 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |